|
US20020072509A1
(en)
*
|
2000-10-11 |
2002-06-13 |
Stein Donald Gerald |
Methods for the treatment of a traumatic central nervous system injury
|
|
SE0104423D0
(sv)
*
|
2001-12-27 |
2001-12-27 |
Umecrine Ab |
Pregnane steroids and their use in the treatment of CNS disorders
|
|
US8114860B2
(en)
|
2004-11-18 |
2012-02-14 |
Umecrine Ab |
GABA-steroid antagonists and their use for the treatment of CNS disorders
|
|
RU2413516C2
(ru)
*
|
2004-11-18 |
2011-03-10 |
Умекрин Аб |
Гамк-стероидные антагонисты и их применение в лечении нарушений цнс
|
|
DE102006003509A1
(de)
*
|
2006-01-24 |
2007-07-26 |
Grünenthal GmbH |
Kontrazeptivum
|
|
DE102006003508A1
(de)
*
|
2006-01-24 |
2007-07-26 |
Grünenthal GmbH |
Arzneimittel umfassend eine Hormonkombination
|
|
US20070203216A1
(en)
*
|
2006-02-14 |
2007-08-30 |
Bjarke Ebert |
Method of treating inflammatory diseases
|
|
EP2097437B1
(en)
|
2006-11-21 |
2015-05-27 |
Umecrine Cognition AB |
The use of pregnane and androstane steroids for the manufacture of a pharmaceutical composition for the treatment of cns disorders
|
|
JP2010530371A
(ja)
*
|
2007-06-11 |
2010-09-09 |
ユニバーシティ オブ サザン カリフォルニア |
神経学的機能を増強するための作用物質、組成物および方法
|
|
US20100204192A1
(en)
|
2007-06-11 |
2010-08-12 |
University Of Sourthern California |
Agents, compositions and methods for enhancing neurological function
|
|
US20090048288A1
(en)
*
|
2007-08-13 |
2009-02-19 |
H. Lundbeck A/S |
Method of treating stress-mediated depression
|
|
US20120322781A1
(en)
*
|
2010-01-14 |
2012-12-20 |
Umecrine Mood Ab |
Pharmaceutical composition comprising 3-beta-hydroxy-5-alpha-pregnan-20-one with improved storage and solubility properties
|
|
CN103764151B
(zh)
*
|
2011-05-20 |
2017-05-17 |
国家医疗保健研究所 |
Cb1受体拮抗剂
|
|
WO2013043985A1
(en)
|
2011-09-23 |
2013-03-28 |
The Regents Of The University Of California |
Edible oils to enhance delivery of orally administered steroids
|
|
WO2013112605A2
(en)
|
2012-01-23 |
2013-08-01 |
Sage Therapeutics, Inc. |
Neuroactive steroid formulations and methods of treating cns disorders
|
|
WO2014028398A2
(en)
|
2012-08-13 |
2014-02-20 |
The Regents Of The University Of California |
Mitigation of epileptic seizures by combination therapy using benzodiazepines and neurosteroids
|
|
HUE056838T2
(hu)
|
2012-08-21 |
2022-04-28 |
Sage Therapeutics Inc |
Allopregnanolon makacs epileptikus állapot kezelésére
|
|
HUE032190T2
(en)
|
2012-11-28 |
2017-09-28 |
Inst Nat De La Sante Et De La Rech Medicale (Inserm) |
3- (4'-substituted) benzyl ether derivatives of pregnenolone
|
|
WO2014085668A1
(en)
|
2012-11-30 |
2014-06-05 |
The Regents Of The University Of California |
Anticonvulsant activity of steroids
|
|
US20160339040A1
(en)
|
2014-01-29 |
2016-11-24 |
Umecrine Cognition Ab |
Steroid compound for use in the treatment of hepatic encephalopathy
|
|
JOP20200195A1
(ar)
|
2014-09-08 |
2017-06-16 |
Sage Therapeutics Inc |
سترويدات وتركيبات نشطة عصبياً، واستخداماتها
|
|
JP6893173B2
(ja)
*
|
2014-11-27 |
2021-06-23 |
セージ セラピューティクス， インコーポレイテッド |
Ｃｎｓ障害を処置するための組成物および方法
|
|
AR103384A1
(es)
|
2015-01-12 |
2017-05-03 |
Umecrine Cognition Ab |
3a-ETINILO, 3b-HIDROXI, 5a-PREGNAN-20-OXIMA COMO MODULADOR DE GABA
|
|
RU2766155C2
(ru)
|
2016-03-08 |
2022-02-08 |
Сейдж Терапьютикс, Инк. |
Нейроактивные стероиды, их композиции и применения
|
|
US10278977B2
(en)
|
2016-06-06 |
2019-05-07 |
Umecrine Cognition Ab |
Methods for treating hypersomnolence
|
|
LT3565528T
(lt)
*
|
2017-01-09 |
2025-06-25 |
Relmada Therapeutics, Inc. |
Injekcinės suspensijos
|
|
BR112019015362A2
(pt)
|
2017-02-10 |
2020-10-20 |
Asarina Pharma Ab |
3-beta-hidroxi-5-alfa-pregnan-20-ona para uso em tratamento médico
|
|
WO2018147791A1
(en)
*
|
2017-02-10 |
2018-08-16 |
Asarina Pharma Ab |
3-beta-hydroxy-5-alpha-pregnan-20-one for use in treatment of essential tremor
|
|
WO2019075362A1
(en)
*
|
2017-10-12 |
2019-04-18 |
Sage Therapeutics, Inc. |
METHOD OF TREATING CENTRAL NERVOUS SYSTEM DISORDERS WITH NEUROSTEROIDS AND GABAERGIC COMPOUNDS
|
|
WO2019193138A1
(en)
|
2018-04-05 |
2019-10-10 |
Asarina Pharma Aps |
Gaba-a antagonists for treating substance withdrawal disorders
|
|
WO2023040851A1
(zh)
|
2021-09-14 |
2023-03-23 |
南京迈诺威医药科技有限公司 |
一种水溶性别孕烷醇酮衍生物及其制备方法和用途
|
|
CA3237550A1
(en)
|
2021-11-10 |
2023-05-19 |
Umecrine Ab |
3.alpha.-substituted 3.beta.-hydroxy 17-oximated androstane compound for modulation of the alpha-3 subtype of the gaba-a receptor
|
|
WO2023083980A1
(en)
|
2021-11-10 |
2023-05-19 |
Umecrine Ab |
Steroid as a modulator of gabaa receptor
|
|
EP4430056A1
(en)
|
2021-11-10 |
2024-09-18 |
Umecrine AB |
3.beta.-hydroxy, 3.alpha.-ethyl steroids for modulation of the alpha-3 subtype of the gaba-a receptor
|